Megan Barnet
@meg_barnet
attempting to strike a balance between motherhood, medical oncology, immunology research and *life (*stuff that happens in between)
ID: 2837913834
02-10-2014 12:08:41
226 Tweet
285 Takipçi
269 Takip Edilen
KN585 OS (noting EFS/trial stat. neg despite 20m improvement) OS benefit 6% at5yrs. FLOT (v CF) backbone did better (cis poor PD1 partner), but only 20% cohort, clear benefit CPS >10/MSI-H. Appealing option; may solidify w MATTERHORN survival (100% FLOT) Kohei shitara #ESMOGI24
